Mass profiling of serum to distinguish mice with pancreatic cancer induced by a transgenic Kras mutation.
Mass profiling of serum to distinguish mice with pancreatic cancer induced by a transgenic Kras mutation. Int J Cancer. 2013 Dec 01; 133(11):2662-71.